Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan.
Verschraegen CF, Kudelka AP, Hu W, Vincent M, Kavanagh JJ, Loyer E, Bastien L, Duggal A, De Jager R. Verschraegen CF, et al. Among authors: kudelka ap. Cancer Chemother Pharmacol. 2004 Jan;53(1):1-7. doi: 10.1007/s00280-003-0696-7. Epub 2003 Oct 28. Cancer Chemother Pharmacol. 2004. PMID: 14586557 Clinical Trial.
Systemic therapy for gynecologic cancer.
Kavanagh JJ, Kudelka AP. Kavanagh JJ, et al. Among authors: kudelka ap. Curr Opin Oncol. 1993 Sep;5(5):891-9. doi: 10.1097/00001622-199309000-00019. Curr Opin Oncol. 1993. PMID: 8105975 Review.
The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
Pazdur R, Kudelka AP, Kavanagh JJ, Cohen PR, Raber MN. Pazdur R, et al. Among authors: kudelka ap. Cancer Treat Rev. 1993 Oct;19(4):351-86. doi: 10.1016/0305-7372(93)90010-o. Cancer Treat Rev. 1993. PMID: 8106152 Review.
145 results